A new research initiative — the Australian Diabetes Clinical Trial Network (ADCTN) — aims to increase the number of clinical trials for diabetes.
Established by Diabetes Australia and the Australian Centre for Accelerating Diabetes Innovation (ACADI), the initiative will support diabetes researchers by providing expert review and feedback for clinical trial protocols and grant funding applications.
Diabetes Australia Group CEO Justine Cain said clinical trials are a cornerstone of medical research and innovation because of their real-world application.
“Clinical trials…